Coherus BioSciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE.

CEO

Denny M. Lanfear

CEODenny M. Lanfear

Employees

306

Employees306

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

306

Employees306

CHRS Key Statistics

Market cap

230.40M

Market cap230.40M

Price-Earnings ratio

-0.79

Price-Earnings ratio-0.79

Dividend yield

—

Dividend yield—

Average volume

1.60M

Average volume1.60M

High today

$2.06

High today$2.06

Low today

$1.93

Low today$1.93

Open price

$1.96

Open price$1.96

Volume

907.17K

Volume907.17K

52 Week high

$8.22

52 Week high$8.22

52 Week low

$1.43

52 Week low$1.43

CHRS News

Yahoo Finance 3d

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology Annual Meeting - Yahoo Finance

Coherus BioSciences, Inc. REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell